These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 291301)

  • 1. Kallikrein system during treatment of hematological malignancies.
    Chiba Y; Ishihara H; Haneda Y; Yoshida Y
    Adv Exp Med Biol; 1979; 120A():501-9. PubMed ID: 291301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and experimental studies on aldolase and its isoenzymes in leukemia and allied hematological disorders (author's transl)].
    Sakurada K
    Hokkaido Igaku Zasshi; 1979 Sep; 54(5):501-31. PubMed ID: 294406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prekallikein and kallikrein inhibitor in liver cirrhosis and hepatitis.
    Faciullacci M; Galli P; Monetti MG; Pela I; Del Bianco PL
    Adv Exp Med Biol; 1976; 70(00):201-8. PubMed ID: 1084679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzyme dynamics of the quinine system in the acute phase of the myocardial infarct: levels of kallikreinogen and of the kallikrein inhibitor].
    Del Bianco PL; Sicuteri F; Fumagalli C
    Boll Soc Ital Cardiol; 1972; 17(9):739-46. PubMed ID: 4549727
    [No Abstract]   [Full Text] [Related]  

  • 6. Kallikreinogen-kallikrein enzymatic system in human plasma. Spontaneous and after activation pool determination in healthy boys, through the use of a new kit.
    Vecchiet L; Cacchio M; Cristiano E; Del Boccio G
    Boll Soc Ital Biol Sper; 1979 Jan; 55(1):27-31. PubMed ID: 475914
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of different treatment methods in patients with psoriasis and content of kallikrein and kallikreinogen in blood plasma.
    Kolosovsky ED
    Dermatology; 1994; 188(2):140-1. PubMed ID: 8136541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adenosine deaminase activity in hemoblastoses].
    Krüger W; Müller G; Storch H; Kubel M; Richter V
    Arch Geschwulstforsch; 1983; 53(1):53-9. PubMed ID: 6574729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance to DNA topoisomerase I and II inhibitors in human leukemia, lymphoma, and multiple myeloma.
    Valkov NI; Sullivan DM
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):48-62. PubMed ID: 9408961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells.
    Greenwood MF; Coleman MS; Hutton JJ; Lampkin B; Krill C; Bolium FJ; Holland P
    J Clin Invest; 1977 May; 59(5):889-99. PubMed ID: 265945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kallikreinogen-kallikrein system in the blood serum of patients with enterocolitis].
    Iarovaia GA; Dotsenko VL; Kozhevnikova LT
    Ter Arkh; 1975; 47(12):62-5. PubMed ID: 1224330
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the kallikrein-kinin system of the blood during development of experimental myocardial infarct].
    Frol'kis RA; Gunina LM
    Vopr Med Khim; 1978; 24(6):747-53. PubMed ID: 734974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanosine diphosphate-L-fucose plasma: N-acetylglucosaminide fucosyltransferase as in index of bone marrow hyperplasia after chemotherapy.
    Khilanani P; Chou TH; Kessel D
    Cancer Res; 1978 Jan; 38(1):181-4. PubMed ID: 271043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the plasma kallikreinogen (prekallikrein)-kallikrein enzyme system.
    Sherry S; Colman RW
    Trans Assoc Am Physicians; 1968; 81():40-8. PubMed ID: 5305252
    [No Abstract]   [Full Text] [Related]  

  • 16. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states.
    Colman RW; Mason JW; Sherry S
    Ann Intern Med; 1969 Oct; 71(4):763-73. PubMed ID: 5360288
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
    Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
    BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pattern of serum kallikreinogen-kallikrein system in patients with goiter].
    Doliński J; Bielicki F; Lukieńczuk T; Witkiewicz W; Koziorowski A
    Endokrynol Pol; 1978; 29(1):31-4. PubMed ID: 580605
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of kallikreinogen and kallikrein inhibitors in blood plasma].
    Veremiienko KM; Volokhons'kaia LI; Kizim OI; Meged' NF
    Ukr Biokhim Zh; 1974; 46(2):246-51. PubMed ID: 4545315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.